A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity

8.2K views

⸱

DOI:

10.3791/57588

⸱

July 12th, 2018

 ,  ,  ,  ,  ,  , 

In This Article

Summary

Here, we present a protocol to produce a bispecific antibody GPC3-S-Fab in Escherichia coli. The purified GPC3-S-Fab has potent cytotoxicity against GPC3 positive liver cancer cells.

Abstract

This protocol describes the construction and functional studies of a bispecific antibody (bsAb), GPC3-S-Fab. bsAbs can recognize two different epitopes through their two different arms. bsAbs have been actively studied for their ability to directly recruit immune cells to kill tumor cells. Currently, the majority of bsAbs are produced in the form of recombinant proteins, either as Fc-containing bsAbs or as smaller bsAb derivatives without the Fc region. In this study, GPC3-S-Fab, an antibody fragment (Fab) based bispecific antibody, was designed by linking the Fab of anti-GPC3 antibody GC33 with an anti-CD16 single domain antibody. The GPC3-S-Fab can be expressed in Escherichia coli and purified by two affinity chromatographies. The purified GPC3-S-Fab can specifically bind to and kill GPC3 positive liver cancer cells by recruiting natural killer cells, suggesting a potential application of GPC3-S-Fab in liver cancer therapy.

Introduction

Monoclonal antibodies are now broadly used for cancer treatment1. Due to the flexibility of antibodies, various antibody-based formats have been actively explored. Compared with monoclonal antibodies, bsAbs have two different antigen binding modules, enabling them to recognize two different targets simultaneously and efficiently trigger the recruitment of immune effector cells to target and kill tumor cells2.

Current recombinant bsAb formats can be generally assigned to two classes: Fc-containing bsAbs and bsAbs without an Fc region. Compared with Fc-containing formats that are mostly produced....

Access restricted. Please log in or start a trial to view this content.

Protocol

All of the procedures including human blood collection were approved by the Sun Yat-Sen University Ethics Committee.

1. GPC3-S-Fab Design Strategy

  1. Design GPC3-S-Fab by linking a Fab of anti-GPC3 (humanized GC3313) with an anti-CD16 VHH14 (Figure 1).
  2. Synthesize and clone the VH-CH1-CD16-VHH and VL-CL into the pET26b and pET21a vectors as previously reported12.

2. Transformation and Culture

  1. Add 100 ng of pET26b containing VH-CH1-CD16 (Figure 1A)....

Access restricted. Please log in or start a trial to view this content.

Results

GPC3-S-Fab purification

GPC3-S-Fab was purified from E. coli by a two-step affinity purification, first with Ni-NTA-agarose, followed by IgG-CH1 affinity purification. After the two-step affinity purification, GPC3-S-Fab was purified to homogeneity with the two chains close to 1:1 (Figure 2A). The presence of both VH-CH1-CD16 VHH and VL-CL polypeptides can be identified by .......

Access restricted. Please log in or start a trial to view this content.

Discussion

In this study, we present a strategy to construct a new format of bsAbs, GPC3-S-Fab, which can recruit NK cells targeting GPC3 positive tumor cells. The S-Fab is based on the natural Fab format by adding an anti-CD16 VHH11,12. Compared with the bsAbs containing Fc region, GPC3-S-Fab can easily be produced in the periplasm of bacteria on a large scale.

Using the expression and purification strategy described in the protocol, we obtained.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors declare no conflicts of interest.

Acknowledgements

This work was financially supported by the R&D Plan of Guangdong Province (PR China) (2016A050503028).

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
Shaking incubatorThermo FisherMAXQ 4000
Shaking incubatorZhichengZWYR-D2402
CentrifugeCenceGL-10MD
CentrifugeBeckman coulterAvanti j-26S XPI
Centrifugeeppendorf5810R
Ultraviolet spectrophotometerThermo FisherNanodrop
Analytical polyacrylamide gel electrophoresis apparatusMini-PROTEAN® TetraBio-rad
Trans-blot apparatusCriterionBio-rad
Imaging systemBio-radchemidoc tm XRS+
Fast Protein Liquid chromatogramGE HealthcareAKTA avant
GF columnGE Healthcare28-9909-44 Superdex 200 Increase 10/300 GL
Flow CytometerBeckman coulterFC500
Centrifugeeppendorf5702R
Envision plate readerTECANInfinite F50
Anti His-tageBioscience14-6657-82
anti-Flag-tagSigmaF1804
anti-human(H&L)-488A11013Invitrogen
Anti-mouse IgG HRP-linked antibodyCell Signaling7076S
Ni-NTA-AgaroseTribioscienceTBS9202-100
IgG-CH1 affinity resinThermo Fisher194320005
Ficoll-Plaque PlusGE Healthcare17-1440-03
NK cell enrichment kitStemcell19055
MagnetStemcell18000
CCK8 kitDojindoCK04
DMEMGibcoC11995500CP
RPMI-1640GibcoC11875500CP
Fetal Bovine Serum (FBS)SigmaF2442
TrypsinGibco15050-057
Penicillin-StreptomycinGibco15140-122Cell culture
Standard markerSigma AldrichMWGF200Gel filtration
Isopropyl-b-D-thio-galactopyranoside (IPTG)VWR chemicalsVWRC0487-100G
Dialysis tubingSigma AldrichD0655-100FT
KnanamycineVWRVWRC0408-100G
AmpicillinVWRVWRC0339-100G
TryptoneThermo FisherLP0042B
Yeast ExtractThermo FisherLP0021B
NaClSangon BiotechA100241
Trizma baseSigma AldrichT6791-1KG
EDTASigma AldrichV900106
GlycinealaddinA110752-500g
KClaladdinP112134-500g
MgClSigma AldrichV900020
AgarSangon BiotechA505255-0250
Potassium Phosphate, Monobasic Anhydrous (KH2PO4)VWR7778-77-0
Sodium Phosphate, Dibasic, Anhydrous (Na2HPO4)VWR7558-79-4
2-MercaptoethanolVWR60-24-2
Phenylmethyl Sulfonyl Fluoride (PMSF)VWR329-98-6
LysozymeSigma AldrichL6876-25G
Coomassie Brilliant Blue R250VWRVWRC0472-50G
Bromophenol blueSangon BiotechA500922-25G
Bovine Serum Albumin (BSA)VWRVWRC0332-100G
GlycerolSigma AldrichV900122
100mm x 20mm plastic dishCorning430167
25cm2 flaskCorning430639
96 well cell culture clusterCorning3599
SucroseSangon BiotechA610498-0005
CHOthe Type Culture Collection of the Chinese Academy of SciencesGNHa 3
MHCC-97Hthe Type Culture Collection of the Chinese Academy of SciencesSCSP-528
HepG2the Type Culture Collection of the Chinese Academy of SciencesTCHu 72
Huh7the Type Culture Collection of the Chinese Academy of SciencesTCHu182
Hep3Bthe Type Culture Collection of the Chinese Academy of SciencesTCHu106
NK92ATCCCRL2408

References

  1. Weiner, G. J. Building better monoclonal antibody-based therapeutics. Nature Reviews Cancer. 15 (6), 361-370 (2015).
  2. Rathi, C., Meibohm, B. Clinical pharmacology of bispecific antibody constructs. The Journal of Clinical Pharmacology. 55, Suppl ....

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Explore More Articles

E.coli ExpressionNickel-NTA PurificationNatural Killer CellsCytotoxicity AssayPeriplasmic FractionPBMC IsolationGPC3 BindingAffinity Chromatography